- Home
- RGNX vs GNE Comparison
RGNX vs GNE Comparison
Compare RGNX & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- GNE
- Stock Information
- Founded
- RGNX 2008
- GNE 2011
- Country
- RGNX United States
- GNE United States
- Employees
- RGNX N/A
- GNE N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- GNE Power Generation
- Sector
- RGNX Health Care
- GNE Utilities
- Exchange
- RGNX Nasdaq
- GNE Nasdaq
- Market Cap
- RGNX 451.1M
- GNE 419.3M
- IPO Year
- RGNX 2015
- GNE N/A
- Fundamental
- Price
- RGNX $12.50
- GNE $15.65
- Analyst Decision
- RGNX Strong Buy
- GNE
- Analyst Count
- RGNX 8
- GNE 0
- Target Price
- RGNX $28.50
- GNE N/A
- AVG Volume (30 Days)
- RGNX 525.7K
- GNE 159.3K
- Earning Date
- RGNX 11-05-2025
- GNE 11-05-2025
- Dividend Yield
- RGNX N/A
- GNE 1.94%
- EPS Growth
- RGNX N/A
- GNE 4.51
- EPS
- RGNX N/A
- GNE 0.31
- Revenue
- RGNX $155,782,000.00
- GNE $456,876,000.00
- Revenue This Year
- RGNX $203.79
- GNE $14.60
- Revenue Next Year
- RGNX $0.72
- GNE $8.64
- P/E Ratio
- RGNX N/A
- GNE $38.50
- Revenue Growth
- RGNX 74.95
- GNE 3.75
- 52 Week Low
- RGNX $5.04
- GNE $13.05
- 52 Week High
- RGNX $12.28
- GNE $28.47
- Technical
- Relative Strength Index (RSI)
- RGNX 76.74
- GNE 50.43
- Support Level
- RGNX $10.24
- GNE $14.70
- Resistance Level
- RGNX $11.00
- GNE $15.75
- Average True Range (ATR)
- RGNX 0.63
- GNE 0.49
- MACD
- RGNX 0.28
- GNE 0.18
- Stochastic Oscillator
- RGNX 93.57
- GNE 61.39
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.